Skip to main content
TipRanks
Go Ultimate75% OFF

Marinomed Biotech AG (93Z) Ratios

1 Followers

Marinomed Biotech AG Ratios

DE:93Z's free cash flow for Q2 2024 was €0.00. For the 2024 fiscal year, DE:93Z's free cash flow was increased by €945.30K and operating cash flow was €-945.30K. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 24Mar 23Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio0.742.402.142.753.81
Quick Ratio0.632.131.972.583.79
Cash Ratio0.271.370.961.642.99
Solvency Ratio-0.25-0.22-0.25-0.31-0.80
Operating Cash Flow Ratio-0.47-0.87-0.81-1.23-1.90
Short-Term Operating Cash Flow Coverage-0.65-2.13-6.45-19.30-135.47
Net Current Asset Value€ -17.61M€ -12.18M€ -8.27M€ -2.75M€ 6.70M
Leverage Ratios
Debt-to-Assets Ratio1.491.020.740.550.24
Debt-to-Equity Ratio-2.15-5.4482.542.390.43
Debt-to-Capital Ratio1.871.230.990.710.30
Long-Term Debt-to-Capital Ratio3.151.260.990.700.29
Financial Leverage Ratio-1.44-5.36111.484.391.79
Debt Service Coverage Ratio-0.43-0.65-1.67-4.55-8.62
Interest Coverage Ratio-3.71-2.29-2.75-9.75-9.33
Debt to Market Cap0.490.270.120.070.03
Interest Debt Per Share15.2716.7711.739.193.74
Net Debt to EBITDA-5.30-4.50-2.80-0.741.19
Profitability Margins
Gross Profit Margin12.45%18.98%12.25%-7.90%-8.34%
EBIT Margin-46.83%-34.43%-35.99%-65.15%-106.54%
EBITDA Margin-39.45%-28.49%-30.76%-59.88%-101.22%
Operating Profit Margin-55.85%-51.01%-35.64%-85.68%-101.07%
Pretax Profit Margin-73.95%-56.68%-48.97%-73.93%-117.37%
Net Profit Margin-73.99%-56.74%-50.67%-73.98%-117.44%
Continuous Operations Profit Margin-73.99%-56.74%-50.67%-73.98%-117.44%
Net Income Per EBT100.06%100.11%103.46%100.06%100.06%
EBT Per EBIT132.39%111.12%137.39%86.29%116.13%
Return on Assets (ROA)-46.50%-28.71%-27.61%-25.57%-37.00%
Return on Equity (ROE)67.03%153.90%-3078.00%-112.18%-66.41%
Return on Capital Employed (ROCE)-103.44%-35.22%-27.05%-38.90%-40.13%
Return on Invested Capital (ROIC)-43.05%-34.83%-25.75%-38.12%-39.78%
Return on Tangible Assets-51.92%-31.24%-30.48%-28.03%-40.37%
Earnings Yield-15.33%-7.57%-4.54%-3.43%-5.09%
Efficiency Ratios
Receivables Turnover3.853.612.421.570.00
Payables Turnover5.257.925.114.446.64
Inventory Turnover7.945.859.939.4768.28
Fixed Asset Turnover1.541.821.811.352.47
Asset Turnover0.630.510.540.350.32
Working Capital Turnover Ratio3.171.491.400.771.66
Cash Conversion Cycle71.21117.49116.46189.16-49.62
Days of Sales Outstanding94.77101.15151.06232.870.00
Days of Inventory Outstanding45.9662.4136.7638.565.35
Days of Payables Outstanding69.5146.0871.3682.2754.96
Operating Cycle140.73163.57187.82271.435.35
Cash Flow Ratios
Operating Cash Flow Per Share-2.98-3.47-3.30-4.68-5.39
Free Cash Flow Per Share-3.07-3.62-3.92-7.37-7.04
Dividend Paid and CapEx Coverage Ratio-35.24-22.86-5.30-1.74-3.26
Capital Expenditure Coverage Ratio-35.24-22.86-5.30-1.74-3.26
Operating Cash Flow Coverage Ratio-0.21-0.23-0.31-0.54-1.65
Operating Cash Flow to Sales Ratio-0.49-0.46-0.42-0.85-1.24
Free Cash Flow Yield-10.50%-6.42%-4.45%-6.20%-7.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-6.52-13.21-22.05-29.13-19.65
Price-to-Sales (P/S) Ratio4.837.5011.1721.5523.08
Price-to-Book (P/B) Ratio-4.37-20.34678.5532.6813.05
Price-to-Free Cash Flow (P/FCF) Ratio-9.52-15.57-22.45-16.14-14.21
Price-to-Operating Cash Flow Ratio-9.79-16.25-26.69-25.43-18.56
Price-to-Earnings Growth (PEG) Ratio-1.33-1.889.021.480.57
Enterprise Value Multiple-17.54-30.81-39.11-36.73-21.61
Enterprise Value63.54M98.99M139.87M178.69M134.43M
EV to EBITDA-17.54-30.81-39.11-36.73-21.61
EV to Sales6.928.7812.0321.9921.88
EV to Free Cash Flow-13.64-18.23-24.18-16.47-13.47
EV to Operating Cash Flow-14.03-19.03-28.74-25.95-17.59
Tangible Book Value Per Share-7.68-3.98-1.232.246.52
Shareholders’ Equity Per Share-6.68-2.770.133.647.66
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.03-0.00-0.00
Revenue Per Share6.057.527.885.524.33
Net Income Per Share-4.48-4.27-3.99-4.09-5.09
Tax Burden1.001.001.031.001.00
Interest Burden1.581.651.361.131.10
Research & Development to Revenue0.000.610.650.730.78
SG&A to Revenue0.110.120.090.130.19
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.670.810.831.151.06

Currency in EUR